Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Public ClinicalTrials.gov record NCT02715258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Compare the Efficacy and Safety of Bexagliflozin to Placebo in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM).
Study identification
- NCT ID
- NCT02715258
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2016 (Actual)
- Primary completion
- Apr 2017 (Actual)
- Completion
- Apr 2017 (Actual)
- Last update posted
- Jun 28, 2021
2016 – 2017
United States locations
- U.S. sites
- 18
- U.S. states
- 8
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Canoga Park | California | 91303 | — |
| Research Site | Chino | California | 91710 | — |
| Research Site | Huntington Park | California | 90255 | — |
| Research Site | Los Angeles | California | 90057 | — |
| Research Site | San Diego | California | 92103 | — |
| Research Site | Fort Lauderdale | Florida | 33316 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Miami Lakes | Florida | 33016 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Port Orange | Florida | 32127 | — |
| Research Site | Trenton | New Jersey | 08611 | — |
| Research Site | Calabash | North Carolina | 28467 | — |
| Research Site | Morehead City | North Carolina | 28557 | — |
| Research Site | Munroe Falls | Ohio | 44262 | — |
| Research Site | Portland | Oregon | 97239 | — |
| Research Site | North Myrtle Beach | South Carolina | 29582 | — |
| Research Site | DeSoto | Texas | 75115 | — |
| Research Site | Fort Worth | Texas | 76164 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02715258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02715258 live on ClinicalTrials.gov.